GleamWall
中文EN

PODD INSULET CORP

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1145197 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY26.5%
TTM net income YoY74.2%
TTM EPS YoY78.4%
Revenue 3-yr CAGR27.0%
Net income 3-yr CAGR52.9%

Margins

Gross margin71.9%
Operating margin18.4%
Net margin13.4%
FCF margin8.2%
EBITDA margin21.7%

Returns

ROE28.9%
ROA13.3%
ROIC (approx.)25.5%
Asset turnover0.99x

Leverage & solvency

Liabilities / assets53.8%
Debt / equity0.61x
Current ratio2.51x
Interest coverage9.91x

Cash quality & payout

Operating cash flow / net income1.19x
Accruals ratio-2.5%
Payout ratio—
Capex / revenue7.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$2.71B$2.07B
Cost of revenue$768.20M$625.90M
Gross profit$1.94B$1.45B
R&D expense$301.10M$219.60M
SG&A expense$1.17B$917.20M
Operating income$473.80M$308.90M
Interest expense$59.40M$42.70M
Pretax income$339.50M$300.20M
Income tax$92.40M-$118.10M
Net income$247.10M$418.30M
EBITDA$564.20M$389.70M
EPS (basic)3.515.97
EPS (diluted)3.485.78
Weighted avg. shares (diluted)71.89M73.89M
Balance sheet
Cash & equivalents$716.10M$953.40M
Receivables$516.90M—
Inventory$452.60M$430.40M
Current assets$1.91B$1.89B
PP&E, net$819.50M$723.10M
Goodwill$51.60M$51.50M
Intangibles$117.10M$98.50M
Total assets$3.19B$3.09B
Current liabilities$680.10M$528.40M
Short-term debt$18.40M$83.80M
Long-term debt$930.80M$1.30B
Total debt$949.20M$1.38B
Total liabilities$1.68B$1.88B
Shareholders' equity$1.52B$1.21B
Net debt$233.10M$426.50M
Shares outstanding70.39M70.20M
Cash flow statement
Operating cash flow$569.30M$430.20M
Capital expenditure$191.60M$124.90M
Free cash flow$377.70M$305.30M
Investing cash flow-$222.70M-$146.20M
Financing cash flow-$595.30M-$28.00M
Depreciation & amortization$90.40M$80.80M
Stock-based compensation$62.70M$69.30M
Share buybacks$59.60M$0

Free plan shows the latest 2 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.